Israel Chemicals Ltd. (NYSE:ICL) released its quarterly earnings results on Wednesday. The company reported $0.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.09. The business had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.51 billion. Israel Chemicals had a return on equity of 17.44% and a net margin of 7.40%. The company’s revenue was up .3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.12 EPS.

Shares of Israel Chemicals (NYSE:ICL) opened at 3.80 on Thursday. The stock has a market cap of $4.84 billion, a price-to-earnings ratio of 11.99 and a beta of 1.14. Israel Chemicals has a 1-year low of $3.52 and a 1-year high of $5.23. The company has a 50-day moving average price of $3.74 and a 200-day moving average price of $3.99.

Earnings History for Israel Chemicals (NYSE:ICL)

Separately, Zacks Investment Research cut Israel Chemicals from a “buy” rating to a “hold” rating in a report on Wednesday, November 2nd.

A number of institutional investors have recently modified their holdings of ICL. JPMorgan Chase & Co. boosted its position in shares of Israel Chemicals by 56.5% in the first quarter. JPMorgan Chase & Co. now owns 357,335 shares of the company’s stock worth $1,533,000 after buying an additional 129,051 shares in the last quarter. AMP Capital Investors Ltd boosted its stake in Israel Chemicals by 13.9% in the first quarter. AMP Capital Investors Ltd now owns 398,097 shares of the company’s stock worth $1,748,000 after buying an additional 48,637 shares during the period. Barclays PLC boosted its stake in Israel Chemicals by 122.1% in the first quarter. Barclays PLC now owns 85,017 shares of the company’s stock worth $340,000 after buying an additional 46,732 shares during the period. Nikko Asset Management Americas Inc. boosted its stake in Israel Chemicals by 1.2% in the second quarter. Nikko Asset Management Americas Inc. now owns 714,283 shares of the company’s stock worth $2,807,000 after buying an additional 8,800 shares during the period. Finally, Bank of Montreal Can acquired a new stake in Israel Chemicals during the second quarter worth $803,000. 6.51% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: This story was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another website, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.thecerbatgem.com/2016/11/24/israel-chemicals-ltd-icl-releases-earnings-results-hits-expectations.html.

5 Day Chart for NYSE:ICL

Receive News & Stock Ratings for Israel Chemicals Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals Ltd. and related stocks with our FREE daily email newsletter.